Key result
Hepatic overexpression of angiotensinogen in transgenic rats increased systolic blood pressure by 26 mmHg and amplified plasma and renal Ang-II responses, which were reduced by lisinopril.
Answers are grounded in this paper and cite their sources.
High plasma angiotensinogen amplifies the plasma and renal Ang-II response, facilitating hypertension and increasing the blood pressure-lowering effect of lisinopril.
OBJECTIVE: Increases in plasma angiotensinogen (Ang-N) due to genetic polymorphisms or pharmacological stimuli like estrogen have been associated with a blood pressure (BP) rise, increased salt sensitivity and cardiovascular risk. The relationship between Ang-N, the resetting of the renin-angiotensin system, and BP still remains unclear. Angiotensin (Ang) II-induced genetic hypertension should respond to lisinopril treatment. METHODS: A new transgenic rat line (TGR) with hepatic overexpression of native (rat) Ang-N was established to study high plasma Ang-N. The transgene contained a mutation producing Val(5)-Ang-II, which was measured separately from nontransgenic Ile-Ang-II in plasma and renal tissue. RESULTS: Male homozygous TGR had increased plasma Ang-N (~20-fold), systolic BP (ΔBP+26 mmHg), renin activity (~2-fold), renin activity/concentration (5-fold), total Ang-II (~2-fold, kidney 1.7-fold) but decreased plasma renin concentrations (-46%, kidney -85%) and Ile(5)-Ang-I and II (-93%, -94%) vs. controls. Heterozygous TGR exhibited ~10-fold higher plasma Ang-N and 17 mmHg ΔBP. Lisinopril decreased their SBP (-23 vs. -13 mmHg in controls), kidney Ang-II/I (~3-fold vs. ~2-fold) and Ile(5)-Ang-II (-70 vs. -40%), and increased kidney renin and Ile(5)-Ang-I (>2.5-fold vs. <2.5-fold). Kidney Ang-II remained higher and renin lower in TGR compared with controls. CONCLUSION: High plasma Ang-N increases plasma and kidney Ang-II levels, and amplifies the plasma and renal Ang-II response to a given change in renal renin secretion. This enzyme-kinetic amplification dominates over the Ang-II mediated feedback reduction of renin secretion. High Ang-N levels thus facilitate hypertension via small increases of Ang II and may influence the effectiveness of renin-angiotensin system inhibitors.
No takes yet. Share an insight, caveat, or question.
Bohlender et al. (2012) studied Hypertension. Lisinopril vs. Controls (nontransgenic rats) was evaluated on Systolic blood pressure and renin-angiotensin system components. Hepatic overexpression of angiotensinogen in transgenic rats increased systolic blood pressure by 26 mmHg and amplified plasma and renal Ang-II responses, which were reduced by lisinopril.
Synapse has enriched 10 related papers. Consider them for comparative context: